查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401996

2030 年维生素 B6 原料药市场预测：按类型、纯度、应用和地区分類的全球分析

Vitamin B6 API Market Forecasts to 2030 - Global Analysis By Type (Capsules, Cream, Liquid and Injection, Syrup, Tablets and Other Types), Purity, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球维生素 B6原料药市场规模为 2.216 亿美元，预计到 2030 年将达到 4.051 亿美元，预测期内复合年增长率为 9.0%。

在製药业，维生素 B6原料药药物成分市场主要涉及生产、销售和分销药用活性维生素 B6的部门。水溶性维生素 B6，也称为吡哆醇，对于人体的新陈代谢、神经传导物质合成和血红蛋白的产生至关重要。解决各种健康问题和提高整体福祉是维生素 B6原料药产业的重要目标。维生素 B6 是参与人体内多种代谢过程的重要辅酶，通常称为吡哆醇。

Proactive health 的研究显示，44% 的美国消费者在食品增加了营养补充的购买量。根据美国食品药物管理局(FDA) 的数据，大约 28-36% 的普通人群使用含有维生素 B6（吡哆醇）的食品补充品。

健康意识不断增强

随着人们越来越认识到维生素 B6 在整体健康（包括代谢过程和神经健康）中发挥的重要作用，对维生素 B6 作为活性药物成分的需求不断增加。为了支持重要的生理活动并解决缺陷问题，消费者迫切寻求食品维生素 B6 的药物配方和营养补充。此外，由于消费者越来越意识到维生素缺乏与许多健康问题和健康意识生活方式之间的联繫，製药和营养补充食品正在将维生素 B6原料药纳入各种产品中。

发展中地区认知度低

在许多开发中国家，补充维生素 B6 的重要性及其健康益处尚未被广泛了解。由于公众和医疗专业人员对该问题缺乏了解，含有维生素 B6 活性成分的药物原料药的采用受到阻碍。由于缺乏对维生素 B6 在支持各种生物功能和解决营养缺乏方面的作用的了解，正在对相关产品市场产生负面影响。教育计划和宣传宣传活动对于解决这一知识差距并为消费者和医疗保健专业人员提供他们所需的资讯以做出有关维生素 B6 补充剂的明智选择至关重要。

高龄化率上升

世界高龄化正在加剧与老龄化相关的健康问题，例如心血管和神经系统疾病，其中一些疾病可能会受到维生素 B6 缺乏的影响。由于老年人通常难以充分吸收营养，因此补充维生素 B6 对于控制维生素 B6 缺乏和促进整体健康至关重要。维生素 B6原料药是药物配方中的关键成分，可满足老年人独特的健康需求，并有助于管理和预防与老龄化相关的疾病。

全球经济挑战

医疗保健支出和消费者购买力可能会受到景气衰退和不确定时期的显着影响。对药品和营养补充剂（尤其是含有维生素 B6原料药的药品和营养补充）的需求下降可归因于可支配收入的下降。在经济状况，补充品和卫生专业人员可能会优先考虑非必要的补充品，而不是基本健康需求所需的补充剂。製药公司可能难以获得研发计划的资金筹措，这可能会阻碍创新产品的开发和推出。

COVID-19 的影响：

市场动态受到全球供应链中断、旅行限制和消费者优先事项变化的影响。儘管由于健康意识的增强，营养补充食品基本上保持稳定，但製药业在分销和製造方面面临挑战。封锁和物流困难可能会影响原料供应并导致工业流程延误。此外，在整个大流行期间，消费者的购买模式受到经济不确定性的影响，进而影响了非必需保健食品的购买。

胶囊细分市场预计将在预测期内成为最大的细分市场

胶囊提供了一种包装维生素 B6原料药的有效方法，确保给药准确并易于纳入日常补充品方案中，因此胶囊细分市场在预测期内占据了最大的市场占有率。胶囊之所以受欢迎，是因为它们容易吞嚥，味道问题较少，而且维生素 B6 含量更稳定。此外，胶囊製剂带来的便利性和精确给药显着增加了消费者的偏好，从而促进了这一领域的快速扩张。利用这一趋势，製药和营养补充食品推出了各种含有维生素B6原料药的胶囊产品，以满足注重健康的补充品市场。

预计肌肉痉挛部分在预测期内复合年增长率最高。

随着维生素对肌肉相关问题的有效性得到证实，肌肉痉挛领域有望盈利的扩张。为了影响肌肉功能，维生素 B6 对于神经传导物质的产生和胺基酸代谢至关重要。随着人们越来越意识到肌肉痉挛和维生素 B6 缺乏之间的联繫，他们正在积极寻找原料药来预防和缓解这些不适。此外，正在开发有针对性的药物和营养补充食品，以解决通常与这种重要物质的缺乏有关的肌肉疼痛。

占有率最高的地区：

由于对预防性医疗保健的重视和健康意识的不断提高，预计亚太地区将占据最大的市场份额。随着人们意识到补充维生素 B6 的重要性，含有维生素 B6原料药的产品的消费率呈指数级增长。此外，消费者积极寻求改善整体健康和解决维生素缺乏的方法，推动了对维生素 B6 活性原料药强化药物製剂的需求。

复合年增长率最高的地区

预计亚太地区将出现盈利成长。政府促进健康和保健的措施以及越来越多拥有可支配资金的中等收入者创造了良好的市场环境。确保药品品质和安全的法律规范增强了消费者信心，进一步支持该地区的市场扩张。此外，食品地区的营养补充和製药部门也证明了其对新产品开发和技术创新的奉献精神。

免费客製化服务

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场参与企业的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计/预测/复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球维生素 B6原料药市场：依类型

  • 介绍
  • 胶囊
  • 奶油
  • 液体和注射剂
  • 糖浆
  • 药片
  • 其他类型

第六章全球维生素 B6原料药市场：依纯度

  • 介绍
  • 食品级
  • 饲料级

第七章全球维生素 B6原料药市场：依应用分类

  • 介绍
  • 贫血
  • 不适
  • 失眠
  • 停经
  • 肌肉痉挛
  • 月经症候群
  • 保水能力
  • 製药业
  • 食品和饮料业
  • 动物营养
  • 其他用途

第八章全球维生素 B6原料药市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 中东和非洲其他地区

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司简介

  • DSM Sinochem Pharmaceuticals
  • Lonza Group Ltd
  • Hegno Pharmaceutical Co., Ltd
  • BASF SE
  • Dishman Carbogen Amcis Ltd
  • Zhejiang NHU Co., Ltd
  • Jiangxi Tianxin Pharmaceutical Co., Ltd
  • Huazhong Pharmaceutical Co., Ltd
  • Tianjin Zhongrui Pharmaceutical Co., Ltd
  • Anhui Sunhere Pharmaceutical Excipients Co., Ltd
  • Anhui Tiger Biotech Co., Ltd
  • Taizhou Tianrui Chemical Co., Ltd
  • Hubei Gedian Humanwell Pharmaceutical Co., Ltd
Product Code: SMRC24516

According to Stratistics MRC, the Global Vitamin B6 API Market is accounted for $221.6 million in 2023 and is expected to reach $405.1 million by 2030 growing at a CAGR of 9.0% during the forecast period. In the pharmaceutical industry, the market for Vitamin B6 API (Active Pharmaceutical Ingredient) pertains to the division that manufactures, sells, and distributes the active form of Vitamin B6, mostly for medicinal purposes. The water-soluble vitamin B6, also referred to as pyridoxine, is crucial for the body's metabolism, the synthesis of neurotransmitters, and the production of hemoglobin. Addressing a variety of health issues and enhancing general well-being are important objectives for the vitamin B6 API industry. A vital coenzyme involved in several metabolic processes in the human body is vitamin B6, often known as pyridoxine.

According to a survey by Proactive health, 44% of US consumers have increased purchases of dietary supplements during the pandemic. According to the U.S. Food and Drug Administration (FDA), about 28-36% of the normal population uses food supplements that contain vitamin B6 (pyridoxine).

Market Dynamics:

Driver:

Increasing health awareness

The demand for Vitamin B6 as an active pharmaceutical ingredient has increased as individuals become increasingly conscious of the critical role vitamins play in overall well-being, including metabolic processes and neurological health. In order to support vital physiological activities and handle inadequacies, consumers are diligently looking for pharmaceutical formulations and nutritional supplements enhanced with vitamin B6. Additionally, vitamin B6 API has been included in a variety of products by the pharmaceutical and nutraceutical industries as a result of growing consumer awareness of the connection between vitamin deficiencies and a number of health issues and health-conscious lifestyles.

Restraint:

Limited awareness in developing regions

The significance of vitamin B6 supplementation and its possible health benefits are not widely understood in many underdeveloped nations. The adoption of pharmaceutical formulations containing Vitamin B6 API is hampered by the general public's and healthcare professionals' lack of understanding of this issue. The market for related products is negatively impacted by a lack of knowledge on the role that vitamin B6 performs in supporting different biological functions and addressing nutritional deficits. To address this knowledge gap and provide consumers and healthcare professionals with the information they need to make informed choices about vitamin B6 supplementation, educational programs and awareness campaigns are crucial.

Opportunity:

Rising aging population

An aging population around the world has contributed to a rise in age-related health concerns, including cardiovascular disease and neurological diseases, several of which can be impacted by vitamin B6 deficiency. Supplementing with Vitamin B6 is essential for managing deficiencies and promoting general health because the senior population frequently experiences difficulties with adequate nutrient absorption. Vitamin B6 API is a crucial component of pharmaceutical formulations that address the unique health requirements of the elderly population and aid in the management and prevention of age-related illnesses.

Threat:

Global economic challenges

Spending on healthcare and consumer purchasing power can be severely impacted by economic downturns and periods of uncertainty. A decrease in the demand for medications and nutritional supplements, particularly those containing vitamin B6 API, may result from lower disposable income. In difficult financial times, individuals and healthcare professionals might give priority to non-essential supplements over those that are necessary for basic health needs. Pharmaceutical businesses might have problems obtaining funding for R&D projects, which could hinder their ability to innovate and launch innovative products.

COVID-19 Impact:

The market dynamics were impacted by disruptions in global supply chains, travel restrictions, and changes in consumer priorities. Due to growing health consciousness, the market for nutritional supplements remained mostly stable, but the pharmaceutical sector experienced difficulties with distribution and manufacture. Lockdowns and logistical difficulties impacted raw material supply, which could cause industrial processes to be delayed. Furthermore, throughout the pandemic, consumer buying patterns were impacted by economic uncertainty, which in turn affected the purchase of non-essential health products.

The capsules segment is expected to be the largest during the forecast period

Because capsules offer an effective means to package vitamin B6 API, ensuring precise dosing and simple incorporation into daily supplement regimens, the capsules sector held the largest share of the market over the projected period. The reason for the popularity of capsules is that they are easier to swallow, have fewer taste-related problems, and have better stability for the vitamin B6 that is inside. Moreover, due to the perceived convenience and accurate dosing that encapsulated formulations provide, consumer preferences have increased substantially, which has contributed to the segment's rapid expansion. Utilizing the benefit of this trend, pharmaceutical and nutraceutical businesses are launching a range of capsule products containing Vitamin B6 API to satisfy the market for wellness-focused supplements.

The muscular cramps segment is expected to have the highest CAGR during the forecast period

The muscle cramps area is anticipated to have profitable expansion due to the vitamin's established effectiveness in treating muscle-related problems. In order to affect muscular function, vitamin B6 is essential for the production of neurotransmitters and the metabolism of amino acids. As individuals become more aware of the connection between muscle cramps and vitamin B6 insufficiency, they are actively searching for formulations that contain vitamin B6 API in order to prevent and relieve these types of discomfort. Additionally, targeted pharmaceutical and nutraceutical solutions have been developed in response to muscle cramps, which are frequently associated with deficits in this vital substance.

Region with largest share:

Because of the increased emphasis on preventive healthcare and the development of health awareness, the Asia-Pacific region is expected to hold the largest proportion of the market. Vitamin B6 API-containing products are being consumed at an exponentially higher rate as people realize the significance of supplementing with nutrients. Additionally, demand for pharmaceutical formulations enhanced with Vitamin B6 API is being driven by consumers actively looking for ways to improve overall well-being and address vitamin deficiencies.

Region with highest CAGR:

Asia Pacific region is expected to hold profitable growth. A favorable market environment has been established by government measures that promote health and wellness as well as by the growing middle-class population with disposable funding. Consumer confidence has been bolstered by regulatory frameworks guaranteeing the quality and safety of pharmaceuticals, which has further propelled the market's expansion in the area. In addition, the Asia-Pacific region's nutraceutical and pharmaceutical sectors have proven their dedication to new product development and innovation.

Key players in the market:

Some of the key players in Vitamin B6 API market include DSM Sinochem Pharmaceuticals, Lonza Group Ltd, Hegno Pharmaceutical Co., Ltd, BASF SE, Dishman Carbogen Amcis Ltd, Zhejiang NHU Co., Ltd, Jiangxi Tianxin Pharmaceutical Co., Ltd, Huazhong Pharmaceutical Co., Ltd, Tianjin Zhongrui Pharmaceutical Co., Ltd, Anhui Sunhere Pharmaceutical Excipients Co., Ltd, Anhui Tiger Biotech Co., Ltd, Taizhou Tianrui Chemical Co., Ltd and Hubei Gedian Humanwell Pharmaceutical Co., Ltd.

Key Developments:

In November 2023, BASF increases defoamer capacity at its Dilovasi plant in Turkey. New production line set up to meet growing demand for Foamaster® and Foamstar® products in South-East Europe, the Middle East and Africa. BASF will improve its service to customers in the region and reduce lead times to ensure faster delivery.

In November 2023, BASF receives funding approval for electrolysis plant. With the approval of funding from the German Federal Ministry for Economic Affairs and Climate Action and the State of Rhineland-Palatinate, BASF has taken a major step closer in building a PEM electrolyser for its project aimed at decarbonising the chemical industry.

Types Covered:

  • Capsules
  • Cream
  • Liquid and Injection
  • Syrup
  • Tablets
  • Other Types

Purities Covered:

  • Food Grade
  • Feed Grade

Applications Covered:

  • Anaemia
  • Fatigue
  • Insomnia
  • Menopausal Depression
  • Muscular Cramps
  • Premenstrual Syndrome
  • Water Retention
  • Pharmaceutical Industry
  • Food & Beverage Industry
  • Animal Nutrition
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Vitamin B6 API Market, By Type

  • 5.1 Introduction
  • 5.2 Capsules
  • 5.3 Cream
  • 5.4 Liquid and Injection
  • 5.5 Syrup
  • 5.6 Tablets
  • 5.7 Other Types

6 Global Vitamin B6 API Market, By Purity

  • 6.1 Introduction
  • 6.2 Food Grade
  • 6.3 Feed Grade

7 Global Vitamin B6 API Market, By Application

  • 7.1 Introduction
  • 7.2 Anaemia
  • 7.3 Fatigue
  • 7.4 Insomnia
  • 7.5 Menopausal Depression
  • 7.6 Muscular Cramps
  • 7.7 Premenstrual Syndrome
  • 7.8 Water Retention
  • 7.9 Pharmaceutical Industry
  • 7.10 Food & Beverage Industry
  • 7.11 Animal Nutrition
  • 7.12 Other Applications

8 Global Vitamin B6 API Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 DSM Sinochem Pharmaceuticals
  • 10.2 Lonza Group Ltd
  • 10.3 Hegno Pharmaceutical Co., Ltd
  • 10.4 BASF SE
  • 10.5 Dishman Carbogen Amcis Ltd
  • 10.6 Zhejiang NHU Co., Ltd
  • 10.7 Jiangxi Tianxin Pharmaceutical Co., Ltd
  • 10.8 Huazhong Pharmaceutical Co., Ltd
  • 10.9 Tianjin Zhongrui Pharmaceutical Co., Ltd
  • 10.10 Anhui Sunhere Pharmaceutical Excipients Co., Ltd
  • 10.11 Anhui Tiger Biotech Co., Ltd
  • 10.12 Taizhou Tianrui Chemical Co., Ltd
  • 10.13 Hubei Gedian Humanwell Pharmaceutical Co., Ltd

List of Tables

  • Table 1 Global Vitamin B6 API Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Vitamin B6 API Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Vitamin B6 API Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 4 Global Vitamin B6 API Market Outlook, By Cream (2021-2030) ($MN)
  • Table 5 Global Vitamin B6 API Market Outlook, By Liquid and Injection (2021-2030) ($MN)
  • Table 6 Global Vitamin B6 API Market Outlook, By Syrup (2021-2030) ($MN)
  • Table 7 Global Vitamin B6 API Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 8 Global Vitamin B6 API Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 9 Global Vitamin B6 API Market Outlook, By Purity (2021-2030) ($MN)
  • Table 10 Global Vitamin B6 API Market Outlook, By Food Grade (2021-2030) ($MN)
  • Table 11 Global Vitamin B6 API Market Outlook, By Feed Grade (2021-2030) ($MN)
  • Table 12 Global Vitamin B6 API Market Outlook, By Application (2021-2030) ($MN)
  • Table 13 Global Vitamin B6 API Market Outlook, By Anaemia (2021-2030) ($MN)
  • Table 14 Global Vitamin B6 API Market Outlook, By Fatigue (2021-2030) ($MN)
  • Table 15 Global Vitamin B6 API Market Outlook, By Insomnia (2021-2030) ($MN)
  • Table 16 Global Vitamin B6 API Market Outlook, By Menopausal Depression (2021-2030) ($MN)
  • Table 17 Global Vitamin B6 API Market Outlook, By Muscular Cramps (2021-2030) ($MN)
  • Table 18 Global Vitamin B6 API Market Outlook, By Premenstrual Syndrome (2021-2030) ($MN)
  • Table 19 Global Vitamin B6 API Market Outlook, By Water Retention (2021-2030) ($MN)
  • Table 20 Global Vitamin B6 API Market Outlook, By Pharmaceutical Industry (2021-2030) ($MN)
  • Table 21 Global Vitamin B6 API Market Outlook, By Food & Beverage Industry (2021-2030) ($MN)
  • Table 22 Global Vitamin B6 API Market Outlook, By Animal Nutrition (2021-2030) ($MN)
  • Table 23 Global Vitamin B6 API Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 24 North America Vitamin B6 API Market Outlook, By Country (2021-2030) ($MN)
  • Table 25 North America Vitamin B6 API Market Outlook, By Type (2021-2030) ($MN)
  • Table 26 North America Vitamin B6 API Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 27 North America Vitamin B6 API Market Outlook, By Cream (2021-2030) ($MN)
  • Table 28 North America Vitamin B6 API Market Outlook, By Liquid and Injection (2021-2030) ($MN)
  • Table 29 North America Vitamin B6 API Market Outlook, By Syrup (2021-2030) ($MN)
  • Table 30 North America Vitamin B6 API Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 31 North America Vitamin B6 API Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 32 North America Vitamin B6 API Market Outlook, By Purity (2021-2030) ($MN)
  • Table 33 North America Vitamin B6 API Market Outlook, By Food Grade (2021-2030) ($MN)
  • Table 34 North America Vitamin B6 API Market Outlook, By Feed Grade (2021-2030) ($MN)
  • Table 35 North America Vitamin B6 API Market Outlook, By Application (2021-2030) ($MN)
  • Table 36 North America Vitamin B6 API Market Outlook, By Anaemia (2021-2030) ($MN)
  • Table 37 North America Vitamin B6 API Market Outlook, By Fatigue (2021-2030) ($MN)
  • Table 38 North America Vitamin B6 API Market Outlook, By Insomnia (2021-2030) ($MN)
  • Table 39 North America Vitamin B6 API Market Outlook, By Menopausal Depression (2021-2030) ($MN)
  • Table 40 North America Vitamin B6 API Market Outlook, By Muscular Cramps (2021-2030) ($MN)
  • Table 41 North America Vitamin B6 API Market Outlook, By Premenstrual Syndrome (2021-2030) ($MN)
  • Table 42 North America Vitamin B6 API Market Outlook, By Water Retention (2021-2030) ($MN)
  • Table 43 North America Vitamin B6 API Market Outlook, By Pharmaceutical Industry (2021-2030) ($MN)
  • Table 44 North America Vitamin B6 API Market Outlook, By Food & Beverage Industry (2021-2030) ($MN)
  • Table 45 North America Vitamin B6 API Market Outlook, By Animal Nutrition (2021-2030) ($MN)
  • Table 46 North America Vitamin B6 API Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 47 Europe Vitamin B6 API Market Outlook, By Country (2021-2030) ($MN)
  • Table 48 Europe Vitamin B6 API Market Outlook, By Type (2021-2030) ($MN)
  • Table 49 Europe Vitamin B6 API Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 50 Europe Vitamin B6 API Market Outlook, By Cream (2021-2030) ($MN)
  • Table 51 Europe Vitamin B6 API Market Outlook, By Liquid and Injection (2021-2030) ($MN)
  • Table 52 Europe Vitamin B6 API Market Outlook, By Syrup (2021-2030) ($MN)
  • Table 53 Europe Vitamin B6 API Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 54 Europe Vitamin B6 API Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 55 Europe Vitamin B6 API Market Outlook, By Purity (2021-2030) ($MN)
  • Table 56 Europe Vitamin B6 API Market Outlook, By Food Grade (2021-2030) ($MN)
  • Table 57 Europe Vitamin B6 API Market Outlook, By Feed Grade (2021-2030) ($MN)
  • Table 58 Europe Vitamin B6 API Market Outlook, By Application (2021-2030) ($MN)
  • Table 59 Europe Vitamin B6 API Market Outlook, By Anaemia (2021-2030) ($MN)
  • Table 60 Europe Vitamin B6 API Market Outlook, By Fatigue (2021-2030) ($MN)
  • Table 61 Europe Vitamin B6 API Market Outlook, By Insomnia (2021-2030) ($MN)
  • Table 62 Europe Vitamin B6 API Market Outlook, By Menopausal Depression (2021-2030) ($MN)
  • Table 63 Europe Vitamin B6 API Market Outlook, By Muscular Cramps (2021-2030) ($MN)
  • Table 64 Europe Vitamin B6 API Market Outlook, By Premenstrual Syndrome (2021-2030) ($MN)
  • Table 65 Europe Vitamin B6 API Market Outlook, By Water Retention (2021-2030) ($MN)
  • Table 66 Europe Vitamin B6 API Market Outlook, By Pharmaceutical Industry (2021-2030) ($MN)
  • Table 67 Europe Vitamin B6 API Market Outlook, By Food & Beverage Industry (2021-2030) ($MN)
  • Table 68 Europe Vitamin B6 API Market Outlook, By Animal Nutrition (2021-2030) ($MN)
  • Table 69 Europe Vitamin B6 API Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 70 Asia Pacific Vitamin B6 API Market Outlook, By Country (2021-2030) ($MN)
  • Table 71 Asia Pacific Vitamin B6 API Market Outlook, By Type (2021-2030) ($MN)
  • Table 72 Asia Pacific Vitamin B6 API Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 73 Asia Pacific Vitamin B6 API Market Outlook, By Cream (2021-2030) ($MN)
  • Table 74 Asia Pacific Vitamin B6 API Market Outlook, By Liquid and Injection (2021-2030) ($MN)
  • Table 75 Asia Pacific Vitamin B6 API Market Outlook, By Syrup (2021-2030) ($MN)
  • Table 76 Asia Pacific Vitamin B6 API Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 77 Asia Pacific Vitamin B6 API Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 78 Asia Pacific Vitamin B6 API Market Outlook, By Purity (2021-2030) ($MN)
  • Table 79 Asia Pacific Vitamin B6 API Market Outlook, By Food Grade (2021-2030) ($MN)
  • Table 80 Asia Pacific Vitamin B6 API Market Outlook, By Feed Grade (2021-2030) ($MN)
  • Table 81 Asia Pacific Vitamin B6 API Market Outlook, By Application (2021-2030) ($MN)
  • Table 82 Asia Pacific Vitamin B6 API Market Outlook, By Anaemia (2021-2030) ($MN)
  • Table 83 Asia Pacific Vitamin B6 API Market Outlook, By Fatigue (2021-2030) ($MN)
  • Table 84 Asia Pacific Vitamin B6 API Market Outlook, By Insomnia (2021-2030) ($MN)
  • Table 85 Asia Pacific Vitamin B6 API Market Outlook, By Menopausal Depression (2021-2030) ($MN)
  • Table 86 Asia Pacific Vitamin B6 API Market Outlook, By Muscular Cramps (2021-2030) ($MN)
  • Table 87 Asia Pacific Vitamin B6 API Market Outlook, By Premenstrual Syndrome (2021-2030) ($MN)
  • Table 88 Asia Pacific Vitamin B6 API Market Outlook, By Water Retention (2021-2030) ($MN)
  • Table 89 Asia Pacific Vitamin B6 API Market Outlook, By Pharmaceutical Industry (2021-2030) ($MN)
  • Table 90 Asia Pacific Vitamin B6 API Market Outlook, By Food & Beverage Industry (2021-2030) ($MN)
  • Table 91 Asia Pacific Vitamin B6 API Market Outlook, By Animal Nutrition (2021-2030) ($MN)
  • Table 92 Asia Pacific Vitamin B6 API Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 93 South America Vitamin B6 API Market Outlook, By Country (2021-2030) ($MN)
  • Table 94 South America Vitamin B6 API Market Outlook, By Type (2021-2030) ($MN)
  • Table 95 South America Vitamin B6 API Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 96 South America Vitamin B6 API Market Outlook, By Cream (2021-2030) ($MN)
  • Table 97 South America Vitamin B6 API Market Outlook, By Liquid and Injection (2021-2030) ($MN)
  • Table 98 South America Vitamin B6 API Market Outlook, By Syrup (2021-2030) ($MN)
  • Table 99 South America Vitamin B6 API Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 100 South America Vitamin B6 API Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 101 South America Vitamin B6 API Market Outlook, By Purity (2021-2030) ($MN)
  • Table 102 South America Vitamin B6 API Market Outlook, By Food Grade (2021-2030) ($MN)
  • Table 103 South America Vitamin B6 API Market Outlook, By Feed Grade (2021-2030) ($MN)
  • Table 104 South America Vitamin B6 API Market Outlook, By Application (2021-2030) ($MN)
  • Table 105 South America Vitamin B6 API Market Outlook, By Anaemia (2021-2030) ($MN)
  • Table 106 South America Vitamin B6 API Market Outlook, By Fatigue (2021-2030) ($MN)
  • Table 107 South America Vitamin B6 API Market Outlook, By Insomnia (2021-2030) ($MN)
  • Table 108 South America Vitamin B6 API Market Outlook, By Menopausal Depression (2021-2030) ($MN)
  • Table 109 South America Vitamin B6 API Market Outlook, By Muscular Cramps (2021-2030) ($MN)
  • Table 110 South America Vitamin B6 API Market Outlook, By Premenstrual Syndrome (2021-2030) ($MN)
  • Table 111 South America Vitamin B6 API Market Outlook, By Water Retention (2021-2030) ($MN)
  • Table 112 South America Vitamin B6 API Market Outlook, By Pharmaceutical Industry (2021-2030) ($MN)
  • Table 113 South America Vitamin B6 API Market Outlook, By Food & Beverage Industry (2021-2030) ($MN)
  • Table 114 South America Vitamin B6 API Market Outlook, By Animal Nutrition (2021-2030) ($MN)
  • Table 115 South America Vitamin B6 API Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 116 Middle East & Africa Vitamin B6 API Market Outlook, By Country (2021-2030) ($MN)
  • Table 117 Middle East & Africa Vitamin B6 API Market Outlook, By Type (2021-2030) ($MN)
  • Table 118 Middle East & Africa Vitamin B6 API Market Outlook, By Capsules (2021-2030) ($MN)
  • Table 119 Middle East & Africa Vitamin B6 API Market Outlook, By Cream (2021-2030) ($MN)
  • Table 120 Middle East & Africa Vitamin B6 API Market Outlook, By Liquid and Injection (2021-2030) ($MN)
  • Table 121 Middle East & Africa Vitamin B6 API Market Outlook, By Syrup (2021-2030) ($MN)
  • Table 122 Middle East & Africa Vitamin B6 API Market Outlook, By Tablets (2021-2030) ($MN)
  • Table 123 Middle East & Africa Vitamin B6 API Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 124 Middle East & Africa Vitamin B6 API Market Outlook, By Purity (2021-2030) ($MN)
  • Table 125 Middle East & Africa Vitamin B6 API Market Outlook, By Food Grade (2021-2030) ($MN)
  • Table 126 Middle East & Africa Vitamin B6 API Market Outlook, By Feed Grade (2021-2030) ($MN)
  • Table 127 Middle East & Africa Vitamin B6 API Market Outlook, By Application (2021-2030) ($MN)
  • Table 128 Middle East & Africa Vitamin B6 API Market Outlook, By Anaemia (2021-2030) ($MN)
  • Table 129 Middle East & Africa Vitamin B6 API Market Outlook, By Fatigue (2021-2030) ($MN)
  • Table 130 Middle East & Africa Vitamin B6 API Market Outlook, By Insomnia (2021-2030) ($MN)
  • Table 131 Middle East & Africa Vitamin B6 API Market Outlook, By Menopausal Depression (2021-2030) ($MN)
  • Table 132 Middle East & Africa Vitamin B6 API Market Outlook, By Muscular Cramps (2021-2030) ($MN)
  • Table 133 Middle East & Africa Vitamin B6 API Market Outlook, By Premenstrual Syndrome (2021-2030) ($MN)
  • Table 134 Middle East & Africa Vitamin B6 API Market Outlook, By Water Retention (2021-2030) ($MN)
  • Table 135 Middle East & Africa Vitamin B6 API Market Outlook, By Pharmaceutical Industry (2021-2030) ($MN)
  • Table 136 Middle East & Africa Vitamin B6 API Market Outlook, By Food & Beverage Industry (2021-2030) ($MN)
  • Table 137 Middle East & Africa Vitamin B6 API Market Outlook, By Animal Nutrition (2021-2030) ($MN)
  • Table 138 Middle East & Africa Vitamin B6 API Market Outlook, By Other Applications (2021-2030) ($MN)